Skip to main content
. 2015 Jul 2;10(7):e0130305. doi: 10.1371/journal.pone.0130305

Table 3. Comparison of AL treatment, timing and adherence between pre- (2009) and post-intervention (2010). All proportions are cluster adjusted.

Pre-intervention (June-July 2009) Post-intervention (July-August 2010)
n/N (%) n/N (%) Difference in proportion (95% CI) P- value**
Source of AL treatment
Public sector 137/506 (27.1) 108/515 (21.0) -6.1 (-11.3, -0.9) 0.07
Formal private sector 5/506 (1.0) 10/515 (1.9) 0.9 (-0.6, 2.4) 0.30
Retail commercial sector 7/506 (1.4) 19/515 (4.0) 2.6 (0.6, 4.6) 0.01
Drugs available in household 8/506 (1.6) 28/515 (5.4) 3.8 (1.6, 6.0) <0.001
AL treatments where treatment started ≥ 4 days ago 147/157 (93.6) 152/165 (92.1) -1.5 (-7.1, 1.4) 0.60
Of all AL treatments where treatment started ≥ 4 days ago number who completed dose 101/147 (68.7) 127/152 (83.5) 14.8 (5.3, 24.3) 0.01
Timing and adherence of AL treatment
Proportion of febrile children accessing AL within 48 hours 93/506 (18.4)* 121/515 (23.5)* 5.1 (0.1, 10.0) 0.06
Proportion of fevers children AL within 48 hours from a public health facility 80/506 (15.8) 70/515 (13.6)** -2.2 (-6.5, 2.1) 0.39
Of all AL treatments within 48 hours and where treatment started > = 4 days ago number who completed dose 56/93 (60.2) 78/121 (64.5) 4.3 (-8.8, 17.4) 0.58
Of all AL treatments within 48 hours from a public health facility and where treatment started ≥ 4 days ago number who completed dose 54/80 (67.5) 57/70 (81.4) 13.9 (0.2, 27.6) 0.05
Proportion of caregivers who sourced AL from public sector who had dose explained 128/137 (93.4) 101/108 (93.5) 0.1 (-6.2, 6.3) 0.98

*Range of proportion across clusters in 2009 (0–33.9%); 2010 (0–52.9%)

**P-value from chi-squared test adjusted for clustering